NORML
MAY 26, 2020
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
Healer
MARCH 26, 2021
That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Care Docs
DECEMBER 11, 2018
It’s hard to get past decades of federal prohibition and criminalization, so it’s little wonder that in 2017 only three percent of adults over 65 years old reported being “current smokers.” [1]. Numerous studies point to that fact, especially in cases surrounding chronic pain and discomfort. Why is that important? Hill, Kevin P.,
Cannabis Law Report
FEBRUARY 7, 2020
According to a University of Auckland article on the audit , CBD oil taken for four weeks significantly improved the self-reported quality of life most for patients with non-cancer chronic pain and anxiety-related mental health conditions. New Zealand’s government eased restrictions on cannabidiol in 2017.
Cannabis Law Report
AUGUST 26, 2019
Chronic pain. One area that reports looked closely was, use of medical marijuana to treat chronic pain. Chronic pain is a foremost cause of disability that affects more than 25 million adults in the U.S. Chronic pain is a foremost cause of disability that affects more than 25 million adults in the U.S.
Cannabis Law Report
JULY 9, 2021
Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].
Weedistry
JANUARY 28, 2019
It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring. Can medical cannabis be the solution? Something needs to be done”: Making medicine attainable and affordable.
Expert insights. Personalized for you.
250 
Let's personalize your content